Harmony Biosciences
HRMY
HRMY
308 hedge funds and large institutions have $1.56B invested in Harmony Biosciences in 2026 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 131 increasing their positions, 96 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
17% less capital invested
Capital invested by funds: $1.87B → $1.56B (-$310M)
38% less call options, than puts
Call options by funds: $12.4M | Put options by funds: $20.1M
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
308
Holding in Top 10
2
Calls
$12.4M
Puts
$20.1M
Top Buyers
| 1 | +$36.9M | |
| 2 | +$34.6M | |
| 3 | +$23.7M | |
| 4 |
Goldman Sachs
New York
|
+$22M |
| 5 |
JP Morgan Chase
New York
|
+$20.5M |
Top Sellers
| 1 | -$21.8M | |
| 2 | -$13.6M | |
| 3 | -$10.9M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$10.9M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$10M |
